In application to ovarian cancer modeling, suppression of GRHL2 was recently shown to inhibit proliferation, invasion, and migration of ovarian cancer cells [265], emphasizing the importance of incorporating this factor into a low-dimensional EOC EMT/MET model. This evidence concerns the gene GRHL2 and ovarian carcinoma.